Document Classification

Section Type: RESULTS

Text: The 24-h trough FEV (1) (primary endpoint ; mean [95 % CI]) was 1. 46 (1. 43, 1. 49) L with indacaterol 600 microg (p < 0. 001 vs. placebo, p < 0. 01 vs. formoterol, p < 0. 05 vs. indacaterol 150 microg), 1. 45 (1. 42, 1. 48) L with indacaterol 300 microg (p < 0. 001 vs. placebo, p < 0. 05 vs. formoterol), 1. 42 (1. 39, 1. 45) L with indacaterol 150 microg (p < 0. 001 vs. placebo), 1. 41 (1. 38, 1. 43) L with formoterol (p < 0. 001 vs. placebo) and 1. 28 (1. 25, 1. 31) L with placebo.